Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of AG1502 in healthy males
NCT02614352Phase 1Unknown
- Sponsor
- Ahn-Gook Pharmaceutical Co., Ltd.
- Primary completion
- Feb 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of atorvastatin + candesartan in hypertension (HTN) and hypercholesterolemia (2 arms), sponsored by Ahn-Gook Pharmaceutical Co., Ltd. Primary endpoints: Maximum Observed Concentration (candesartan cilexetil) at 48 hours, Area Under the Curve from time 0 to last measurable concentration (candesartan cilexetil) at 48 hours and 2 more. Status: unknown.
02
Drugs
atorvastatin + candesartan
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02614352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02614352.